Inventor · disambiguated record
Samuel E. Metobo
Also filed as: METOBO SAMUEL · METOBO SAMUEL E
23 granted patents·13 pending applications·339 citations·filing 2005–2025
95Inventor score
Top patents by PatentIndex Score
36 records- 0198US10988498B2Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogsGILEAD SCIENCES INC·Filed 2018·Granted Apr 27, 2021·28 cites·1 claims
- 0298US9670205B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2016·Granted Jun 6, 2017·100 cites·16 claims
- 0398US7973013B22'-fluoro substituted carba-nucleoside analogs for antiviral treatmentGILEAD SCIENCES INC·Filed 2010·Granted Jul 5, 2011·123 cites·20 claims
- 0496US10285990B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 14, 2019·11 cites·6 claims
- 0595US10023600B2Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogsBUTLER THOMAS·Filed 2010·Granted Jul 17, 2018·37 cites·2 claims
- 0693US10774071B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Sep 15, 2020·7 cites·18 claims
- 0791US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 0889US11453681B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Sep 27, 2022·2 cites·53 claims
- 0989US9458145B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·12 cites·9 claims
- 1083US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 1183US10442804B2Compounds for the treatment of hepatitis B virus infectionGILEAD SCIENCES INC·Filed 2018·Granted Oct 15, 2019·4 cites·20 claims
- 1283US9255089B2Benzimidazolone derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 1378US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1477US12377100B2Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2021·Granted Aug 5, 2025·0 cites·5 claims
- 1577US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 1677US2025353820A1Antiviral pyrazolopyridinone compoundsNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1774US8008287B2Integrase inhibitorsGILEAD SCIENCES INC·Filed 2007·Granted Aug 30, 2011·2 cites·52 claims
- 1872US7998950B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2009·Granted Aug 16, 2011·1 cites·17 claims
- 1970US12037342B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jul 16, 2024·0 cites·54 claims
- 2070US2021403497A1Processes and intermediates for the preparation of 1`-substituted carba-nucleoside analogsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2169US12338220B2Antiviral pyrazolopiridinone compoundsNOVARTIS AG·Filed 2023·Granted Jun 24, 2025·0 cites·21 claims
- 2262US2019282576A1Toll like receptor modulator compoundsGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 2360US12269812B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 8, 2025·0 cites·11 claims
- 2460US11667613B2Antiviral pyrazolopyridinone compoundsNOVARTIS AG·Filed 2020·Granted Jun 6, 2023·0 cites·38 claims
- 2555US2018282316A1Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2655US2024408169A1Cyclin inhibitorsCIRCLE PHARMA INC·Filed 2024·Application pending·0 cites
- 2754US2008076740A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 2852US10017501B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 2950US2009291921A1Integrase inhibitorsGILEAD SCIENCES INC·Filed 2008·Application pending·0 cites
- 3048US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3147US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 3246US11236085B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Feb 1, 2022·0 cites·28 claims
- 3344US2008076738A1Phosphonate Analogs Of Hiv Integrase Inhibitor CompoundsCAI ZHENHONG R·Filed 2005·Application pending·0 cites
- 3444US2006116356A1Phosphonate analogs of HIV integrase inhibitor compoundsCAI ZHENHONG R·Filed 2005·Application pending·0 cites
- 3541US2007072831A1Integrase inhibitor compoundsGILEAD SCIENCES INC·Filed 2006·Application pending·0 cites
- 3639US2017342068A1Compounds for the treatment of hepatitis b virus infectionGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel E. Metobo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →